Evidence map›Paper›PMID 22205149›Full record

Trial reportMenopause (New York, N.Y.)2012

Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms.

Vinod Yalamanchili, J Christopher Gallagher

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Menopause (New York, N.Y.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 9 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 9 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Efficacy of vitamin D supplementation in depression in adults: a systematic review.The Journal of clinical endocrinology and metabolism · 2014
    Pooled it
  9. Pooled it
  10. Trial
  11. Dose ranging effects of vitamin D3 on the geriatric depression score: A clinical trial.The Journal of steroid biochemistry and molecular biology · 2018
    Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Vitamin D level in relation to depression symptoms during adolescence.Child and adolescent psychiatry and mental health · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vinod YalamanchiliBone Metabolism Unit, Creighton University School of Medicine, Omaha, NE 68131, USA. vinod@creighton.edu
J Christopher Gallagher
Creighton University · US

Funding

PATHOPHYSIOLOGY OF SENILE TYPE 11 OSTEOPOROSISR01AG010358 · NIA · CREIGHTON UNIVERSITY · PI GALLAGHER, JOHN CHRISTOPHER · 1991 to 1995
–
TREATMENT FOR OSTEOPOROSIS OF THE HIP-SUPPLEMENT AG10373U01AG010373 · NIA · CREIGHTON UNIVERSITY · PI GALLAGHER, JOHN CHRISTOPHER · 1991 to 1998
–
NIA NIH HHS AG10358NIA NIH HHS U01 AG010373NIA NIH HHS U01-AG10373
6 · The paper itself

Abstract

objectiveThe aim of this study was to examine the effect of hormone therapy and calcitriol on depression in older postmenopausal women and to determine whether the response was associated with polymorphisms of estrogen receptor α and vitamin D receptor.

methodsIn a double-blind placebo-controlled prospective trial involving 489 postmenopausal older women, a secondary analysis of depression was done. The Geriatric Depression Scale was used to screen for depression. We used binary logistic regression to examine the effect of treatment on depression and one-way analysis of variance to find a relationship between gene polymorphisms and depression.

resultsThere was no effect of hormone therapy (odds ratio [OR], 1.65; 95% CI, 0.66-4.12; P = 0.277), calcitriol (OR, 1.15; 95% CI, 0.43-3.11; P = 0.772), or hormone therapy with calcitriol (OR, 1.01; 95% CI, 0.36-2.80; P = 0.979) on depression. Neither the polymorphisms of estrogen receptor α (XbaI-β = 0.093; CI, -0.337 to 1.350; P = 0.239 and PvuII-β = -0.064; CI, -1.171 to 0.491, P = 0.421) nor those of vitamin D receptor (BsmI-β = 0.044, CI -2.546 to 3.030, P = 0.865 and TaqI-β = -0.015, CI -2.900 to 2.738, P = 0.955) were associated with depression.

conclusionIn older postmenopausal women, there was no effect of hormone therapy and calcitriol either individually or in combination with depression. Estrogen receptor α and vitamin D receptor polymorphisms are not associated with depression or the response to intervention in older postmenopausal women. Additional trials are required to confirm these findings.

Indexed as

Estrogen Replacement TherapyPostmenopauseAgedCalcitriolCross-Sectional StudiesDepressionDouble-Blind MethodEstradiolEstrogen Receptor alphaFemaleGenotypeHumansLongitudinal StudiesPlacebosPolymorphism, GeneticReceptors, CalcitriolCalcitriolEstradiolEstrogen Receptor alphaPlacebosReceptors, CalcitriolSex Hormone-Binding GlobulinTestosterone

Identifiers

PMID22205149
PMCPMC3319337
OpenAlexW2090929981

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.